Delivery Order SPE2DB20D3103-SPE2DB21FP8V1
- Not listed
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,420.36 to Amerisourcebergen Drug Corporation for 120 tablets of 1.2 gm LIALDA DR, to be delivered from its Conshohocken, Pennsylvania facility by August 23, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procuring and providing medical supplies to support the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,723.00 firm-fixed-price delivery order contract is for the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices. The contract has an ultimate completion date of May 3, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $9,743.99 for the supply of 60 capsules of the medication Lubiprostone 24 MCG. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 7, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,333.48 firm-fixed-price delivery order is for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $1,053.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
- The U.S. government agency Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of pharmaceutical products and medical supplies. The delivery order, valued at $5,663.17, has a Firm Fixed Price pricing type and an ultimate completion date of April 24, 2023. It is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,146.60, is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (parent company of Amerisourcebergen Drug Corp), worth up to $999,999,999.00 through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,379.88 for the drug LAGEVRIO 200 MG CAP (EUA). The award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and has a completion date of February 9, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, worth $3,053.51, is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,281.84 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen). This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FP8V1Delivery Order
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,705.35 firm fixed-price delivery order is for the supply of 120 tablets of the pharmaceutical product Lialda DR 1.2 GM. The contract has an ultimate completion date of August 16, 2021. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies. This delivery order is part of that larger contracting vehicle, which enables the efficient procurement of essential healthcare commodities to support military and veteran healthcare needs. The contract award did not utilize any set-aside designations, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/13/21 |